Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA: 688192)
China flag China · Delayed Price · Currency is CNY
35.78
-1.81 (-4.82%)
Sep 6, 2024, 4:00 PM CST

Dizal (Jiangsu) Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Cash & Equivalents
102.8574.2121.67364.24509.02206.88
Upgrade
Trading Asset Securities
725.096741,2951,71190.2912.45
Upgrade
Cash & Short-Term Investments
827.93748.21,4162,075599.31219.32
Upgrade
Cash Growth
-19.63%-47.18%-31.74%246.26%173.26%-9.59%
Upgrade
Accounts Receivable
93.748.04-7.556.99.95
Upgrade
Other Receivables
-----0.36
Upgrade
Receivables
93.9948.04-7.556.910.31
Upgrade
Inventory
32.6123.475.07---
Upgrade
Other Current Assets
67.4490.6551.6429.5718.8614.58
Upgrade
Total Current Assets
1,022910.361,4732,112625.07244.21
Upgrade
Property, Plant & Equipment
152.28102.26103.66104.4815.1917.29
Upgrade
Other Intangible Assets
446.29461.98492.02474.9506.25327.16
Upgrade
Long-Term Deferred Charges
12.8416.997.994.543.530.07
Upgrade
Other Long-Term Assets
11.584.795.0649.5131.9838.62
Upgrade
Total Assets
1,6451,4962,0822,7461,182627.36
Upgrade
Accounts Payable
27.7720.228.811.651.06127.84
Upgrade
Accrued Expenses
230.66177.08208.53182.7594.2625.17
Upgrade
Short-Term Debt
203.08200.11----
Upgrade
Current Portion of Long-Term Debt
0.330.1----
Upgrade
Current Portion of Leases
19.9922.9521.3416.84--
Upgrade
Current Income Taxes Payable
-0.050-0.012.02
Upgrade
Current Unearned Revenue
1.920.98----
Upgrade
Other Current Liabilities
62.3326.939.8210.767.7921.92
Upgrade
Total Current Liabilities
546.08448.44248.49211.99103.11176.96
Upgrade
Long-Term Debt
423.67138.31----
Upgrade
Long-Term Leases
39.1548.8963.9370.92--
Upgrade
Long-Term Unearned Revenue
14.5612.1111---
Upgrade
Total Liabilities
1,023647.75323.43282.91103.11176.96
Upgrade
Common Stock
415.65408.15407.16404.183601,095
Upgrade
Additional Paid-In Capital
3,0522,9542,7572,729718.880.12
Upgrade
Retained Earnings
-2,858-2,514-1,406-669.850.03-645.01
Upgrade
Shareholders' Equity
621.51848.631,7582,4631,079450.4
Upgrade
Total Liabilities & Equity
1,6451,4962,0822,7461,182627.36
Upgrade
Total Debt
686.21410.3785.2787.76--
Upgrade
Net Cash (Debt)
141.72337.831,3311,987599.31219.32
Upgrade
Net Cash Growth
-83.67%-74.62%-33.02%231.62%173.26%-9.59%
Upgrade
Net Cash Per Share
0.340.833.295.521.67-
Upgrade
Filing Date Shares Outstanding
415.65408.15407.16404.18360-
Upgrade
Total Common Shares Outstanding
415.65408.15407.16404.18360-
Upgrade
Working Capital
475.9461.931,2251,900521.9767.26
Upgrade
Book Value Per Share
1.472.084.326.093.00-
Upgrade
Tangible Book Value
162.77386.651,2661,988572.66123.24
Upgrade
Tangible Book Value Per Share
0.390.953.114.921.59-
Upgrade
Machinery
52.4449.1431.9926.9123.5919.5
Upgrade
Construction In Progress
76.5113.358.855.040.151.78
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.